<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Bavarian Nordic — Maj 2018]]></title><description><![CDATA[<p dir="auto">Bavarian: ebola i Congo. Jansen siger de har 2 mio doser klar</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/451947/bavarian-nordic-maj-2018</link><generator>RSS for Node</generator><lastBuildDate>Sat, 13 Jun 2026 10:58:44 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/451947.rss" rel="self" type="application/rss+xml"/><pubDate>Sat, 12 May 2018 13:54:13 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Thu, 31 May 2018 04:45:05 GMT]]></title><description><![CDATA[<p dir="auto">Hvilke kurstriggere kan der være for Zealand Pharma de næste 3-6 måneder? Forventes der nogle forsøgsresultater eller andet nyt fra pipelinen?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491308</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491308</guid><dc:creator><![CDATA[JohnW]]></dc:creator><pubDate>Thu, 31 May 2018 04:45:05 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Fri, 25 May 2018 06:51:15 GMT]]></title><description><![CDATA[<p dir="auto">Første gang vi får sat ord på problemerne ved brug af homolog prime-boost med MVA-RSV i går af Chaplin under Q1 Q&amp;A. Jeg tror dog, at vigtigheden af fase 2-boost studiet går henover hovedet på det meste af markedet, som primært kigger mod human challenge og fase 3. Udfaldet heraf skal nok derfor ses som binært, med stærkt negativt vs. neutralt.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491311</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491311</guid><dc:creator><![CDATA[BioBio]]></dc:creator><pubDate>Fri, 25 May 2018 06:51:15 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Thu, 24 May 2018 08:56:30 GMT]]></title><description><![CDATA[<p dir="auto">Jeg har hverken shortet eller købt Bavarian aktier - men jeg bryder mig personligt ikke om det..</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491307</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491307</guid><dc:creator><![CDATA[Bananfluuen]]></dc:creator><pubDate>Thu, 24 May 2018 08:56:30 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Thu, 24 May 2018 08:55:21 GMT]]></title><description><![CDATA[<p dir="auto">Hvad synes chatten om den sidste linje i Børsen interviewet? "Hvad tænker du om, at mange går short i Bavarian-aktien?<br />
"Det viser, at der er interesse i aktien. Hvad kan jeg sige? Jeg har besluttet, at jeg vil købe alle 30.000 aktier og næsten fordoble min andel i det næste vindue. Jeg synes, Bavarian er en meget interessant aktie lige nu."</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491310</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491310</guid><dc:creator><![CDATA[Bananfluuen]]></dc:creator><pubDate>Thu, 24 May 2018 08:55:21 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Thu, 24 May 2018 07:04:44 GMT]]></title><description><![CDATA[<p dir="auto">Regnskab er som sædvanlig et non event i biotek. Men som Paul Chaplin siger, så er der spændende data på vej.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491306</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491306</guid><dc:creator><![CDATA[nik_hs1990]]></dc:creator><pubDate>Thu, 24 May 2018 07:04:44 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Wed, 23 May 2018 16:24:51 GMT]]></title><description><![CDATA[<p dir="auto">Data fra disse studier kan dog blive guld værd senere i AdVac/MVA prime-boost vacciner.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491305</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491305</guid><dc:creator><![CDATA[BioBio]]></dc:creator><pubDate>Wed, 23 May 2018 16:24:51 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Wed, 23 May 2018 16:23:01 GMT]]></title><description><![CDATA[<p dir="auto"><a class="plugin-mentions-user plugin-mentions-a" href="/forum/user/kkjoel" aria-label="Profile: kkjoel">@<bdi>kkjoel</bdi></a>. Denne artikel slår netop fast, at Ebola vaccinen ikke er et kommercielt produkt, men et produkt med fokus på velgørenhed. Merck har indtil nu også doneret vaccine gratis til WHO. <a href="https://finance.yahoo.com/news/why-world-needs-more-one-145540767.html?guccounter=1" rel="nofollow ugc">https://finance.yahoo.com/news/why-world-needs-more-one-145540767.html?guccounter=1</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491309</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491309</guid><dc:creator><![CDATA[BioBio]]></dc:creator><pubDate>Wed, 23 May 2018 16:23:01 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Wed, 23 May 2018 14:32:19 GMT]]></title><description><![CDATA[<p dir="auto">Her situations rapporter hos WHO: <a href="http://www.who.int/ebola/situation-reports/drc-2018/en/" rel="nofollow ugc">http://www.who.int/ebola/situation-reports/drc-2018/en/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491303</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491303</guid><dc:creator><![CDATA[kkjoel]]></dc:creator><pubDate>Wed, 23 May 2018 14:32:19 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Wed, 23 May 2018 14:29:16 GMT]]></title><description><![CDATA[<p dir="auto">Her oversigt i wiki-opslaget: <a href="https://en.wikipedia.org/wiki/Ebola_vaccine" rel="nofollow ugc">https://en.wikipedia.org/wiki/Ebola_vaccine</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491301</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491301</guid><dc:creator><![CDATA[kkjoel]]></dc:creator><pubDate>Wed, 23 May 2018 14:29:16 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Wed, 23 May 2018 14:27:48 GMT]]></title><description><![CDATA[<p dir="auto">Så J&amp;J's vil være ideel til fx sundhedsarbejdere, der skal beskyttes i længere perioder.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491299</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491299</guid><dc:creator><![CDATA[kkjoel]]></dc:creator><pubDate>Wed, 23 May 2018 14:27:48 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Wed, 23 May 2018 14:27:05 GMT]]></title><description><![CDATA[<p dir="auto">Merck's skal kun gives 1 gang og er god til den ringvaccination, man forsøger nu - mens J&amp;J's vaccine gives over to gange, men formodentlig beskytter meget længere.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491300</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491300</guid><dc:creator><![CDATA[kkjoel]]></dc:creator><pubDate>Wed, 23 May 2018 14:27:05 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Wed, 23 May 2018 14:24:29 GMT]]></title><description><![CDATA[<p dir="auto">Godt skriv om de to Ebola "hovedvacciner" - Merck's "VSV EBOV" og J&amp;J/BAVAs "Ad26.ZEBOV/ MVA-BN": <a href="https://finance.yahoo.com/news/why-world-needs-more-one-145540767.html" rel="nofollow ugc">https://finance.yahoo.com/news/why-world-needs-more-one-145540767.html</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491304</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491304</guid><dc:creator><![CDATA[kkjoel]]></dc:creator><pubDate>Wed, 23 May 2018 14:24:29 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Fri, 18 May 2018 12:54:15 GMT]]></title><description><![CDATA[<p dir="auto">Ja man skulle ha´ nogle flere penge til at putte i den.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491296</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491296</guid><dc:creator><![CDATA[bikube]]></dc:creator><pubDate>Fri, 18 May 2018 12:54:15 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Fri, 18 May 2018 09:21:41 GMT]]></title><description><![CDATA[<p dir="auto">Det kan vel let være en blanding af Ebola, delvist positive abstracts fra ASCO som bekræfter at Prostvac ser spændende ud i kombi, en opjustering fra Nordea, samt et generelt lavt kursniveau på det seneste.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491295</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491295</guid><dc:creator><![CDATA[BioBio]]></dc:creator><pubDate>Fri, 18 May 2018 09:21:41 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Fri, 18 May 2018 08:27:03 GMT]]></title><description><![CDATA[<p dir="auto">Hvad er den vigtigste årsag til, at de anonyme køber så voldsomt op idag? Er det Ebolaepidemien, kommende regnskab eller opjusteret kursmål? Det ligner i hvert fald en giftig kombination for shorterne. Ethvert tilløb til "shortsqveese" bliver som sædvanligt kvalt af danske aktionærer, der kaster aktien fra sig ved selv små stigninger. Let the profit run.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491302</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491302</guid><dc:creator><![CDATA[bikube]]></dc:creator><pubDate>Fri, 18 May 2018 08:27:03 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Fri, 18 May 2018 04:41:51 GMT]]></title><description><![CDATA[<p dir="auto">Hævet kursmål Bavarian. <a href="http://www.euroinvestor.dk/nyheder/2018/05/18/bavarian-nordea-haever-anbefaling-til-koeb-fra-hold/13827930" rel="nofollow ugc">http://www.euroinvestor.dk/nyheder/2018/05/18/bavarian-nordea-haever-anbefaling-til-koeb-fra-hold/13827930</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491293</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491293</guid><dc:creator><![CDATA[bibob]]></dc:creator><pubDate>Fri, 18 May 2018 04:41:51 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Thu, 17 May 2018 04:50:25 GMT]]></title><description><![CDATA[<p dir="auto">Tak for din konklusion <a class="plugin-mentions-user plugin-mentions-a" href="/forum/user/biobio" aria-label="Profile: BioBio">@<bdi>BioBio</bdi></a>, som menigmand kan det være lidt svært at følge med <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=de222e39001" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491298</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491298</guid><dc:creator><![CDATA[Tyndeejner]]></dc:creator><pubDate>Thu, 17 May 2018 04:50:25 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Wed, 16 May 2018 19:30:32 GMT]]></title><description><![CDATA[<p dir="auto">Lidt mere nørdede abstracts viser, at Prostvacs effekt på immunforsvaret bedst kan ses i tumorvævet, og ikke via blodprøver, som det ellers tidligere er blevet gjort. <a href="http://abstracts.asco.org/214/AbstView_214_224859.html" rel="nofollow ugc">http://abstracts.asco.org/214/AbstView_214_224859.html</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491294</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491294</guid><dc:creator><![CDATA[BioBio]]></dc:creator><pubDate>Wed, 16 May 2018 19:30:32 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Wed, 16 May 2018 19:25:35 GMT]]></title><description><![CDATA[<p dir="auto">De første data fra 8 patienter i kombinationsforsøget med Prostvac+Opdivo(+Yervoy) i CRPC viser en lovende effekt på PSA niveauet på 2 ud af 6 for Prostvac+Opdivo og 1 ud af 2 for Prostvac+Opdivo+Yervoy. Dette er umiddelbart opløftende, men forsøget har dog ingen kontrolarm, så effekten kan skyldes Opdivo/Yervoy alene.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491297</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491297</guid><dc:creator><![CDATA[BioBio]]></dc:creator><pubDate>Wed, 16 May 2018 19:25:35 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Wed, 16 May 2018 19:19:56 GMT]]></title><description><![CDATA[<p dir="auto">Fra fase 3 forsøget: Prostvac vs. Prostvac+GM-CSF vs. Placebo gav en median overall surival på hhv. 34.8 mnd vs. 33.9 mnd vs. 34.7 mnd. Der var herudfra ikke belæg for, at Prostvac virker bedre end placebo.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491288</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491288</guid><dc:creator><![CDATA[BioBio]]></dc:creator><pubDate>Wed, 16 May 2018 19:19:56 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Wed, 16 May 2018 19:17:01 GMT]]></title><description><![CDATA[<p dir="auto">Bavarian præsenterer data fra Prostvac forsøg på ASCO i juni. Abstracts er blevet offentliggjort nu her kl. 23. Her kan man finde data fra fase 3 forsøget og for kombinationsforsøget med Prostvac + Opdivo (+Yervoy). <a href="http://abstracts.asco.org/214/AbstView_214_224943.html" rel="nofollow ugc">http://abstracts.asco.org/214/AbstView_214_224943.html</a>, <a href="http://abstracts.asco.org/214/AbstView_214_227883.html" rel="nofollow ugc">http://abstracts.asco.org/214/AbstView_214_227883.html</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491291</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491291</guid><dc:creator><![CDATA[BioBio]]></dc:creator><pubDate>Wed, 16 May 2018 19:17:01 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Wed, 16 May 2018 06:24:10 GMT]]></title><description><![CDATA[<p dir="auto">Får vi nogle overraskelser?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491287</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491287</guid><dc:creator><![CDATA[petjan20]]></dc:creator><pubDate>Wed, 16 May 2018 06:24:10 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Wed, 16 May 2018 06:24:05 GMT]]></title><description><![CDATA[<p dir="auto">Hvornår kommer Zealand Q1 regnskab idag?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491289</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491289</guid><dc:creator><![CDATA[petjan20]]></dc:creator><pubDate>Wed, 16 May 2018 06:24:05 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Maj 2018 on Tue, 15 May 2018 14:34:55 GMT]]></title><description><![CDATA[<p dir="auto">Der er nok en del bekymring for en evt. emission pga. manglende indtægter i 2018. Min bekymring er primært data fra RSV fase 2-booster, som burde komme her indenfor den næste 1½ måneds tid.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10491283</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10491283</guid><dc:creator><![CDATA[BioBio]]></dc:creator><pubDate>Tue, 15 May 2018 14:34:55 GMT</pubDate></item></channel></rss>